PCN60 The Cost Study of Treating mCRC With Bevacizumab Plus Chemotherapy in the Real Clinical Practice in the Czech Republic
Abstract
Authors
I. Hradecka B. Rihova R. Horova R. Demlova
I. Hradecka B. Rihova R. Horova R. Demlova
ISPOR recommends that you update your browser for more security, speed and the best experience on ispor.org. Update my browser now